Core Viewpoint - Norwegian Cruise Line Holdings Ltd. has appointed John W. Chidsey as President and CEO, with a compensation structure aimed at aligning his incentives with long-term shareholder value creation [1][2][3]. Employment Agreement - Mr. Chidsey's employment agreement includes an annual base salary of $1,715,000 and a target annual bonus opportunity of 175% of his base salary starting in fiscal year 2027 [4]. - For fiscal 2026, his annual bonus is fixed at $2.9 million, which is below the target amount [4]. Inducement Award - As an inducement for accepting the CEO position, Mr. Chidsey was granted a one-time award of 2,139,892 restricted share units valued at approximately $48 million, structured as a "front-loaded" grant covering four years [5][6]. - The award consists of 1,172,638 performance share units (PSUs) valued at about $28.8 million and 967,254 restricted share units (RSUs) valued at approximately $19.2 million [7]. Vesting Conditions - The RSUs will vest in four equal annual installments starting from March 1, 2026, while the PSUs will cliff vest at the end of a four-year performance period based on total shareholder return (TSR) targets [8]. - Specific TSR CAGR targets are set for PSU vesting: less than 5% results in no vesting, 5% allows for 50% vesting, 10% allows for 100% vesting, and 20% or more allows for 200% vesting [8]. Compensation Committee Review - The Compensation Committee reviewed benchmarks among peers to ensure the grant value was competitive and aligned with shareholder value creation [6]. - Mr. Chidsey's agreement does not allow participation in the company's existing performance incentive plans, differing from other executives [6][11]. Company Overview - Norwegian Cruise Line Holdings operates Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises, with a fleet of 35 ships and nearly 75,000 berths, offering itineraries to approximately 700 destinations [12]. - The company plans to add 16 additional ships by 2037, which will increase its fleet capacity by approximately 43,000 berths [12].

Core Insights - Profound Medical Corp. has announced the successful completion of its 100th TULSA Procedure™ at Dallas Medical Center, marking a significant milestone in the adoption of its innovative prostate treatment technology [1][2] Company Overview - Profound Medical Corp. is a commercial-stage medical device company focused on developing AI-powered, MRI-guided, incision-free therapies for treating diseased tissue, particularly in prostate care [1][3] - The company's flagship product, the TULSA-PRO system, allows for precise, real-time MRI-guided prostate therapy, enhancing treatment personalization and minimizing side effects associated with traditional surgical methods [4][6] Technology and Innovation - The TULSA Procedure utilizes robotically controlled directional ultrasound to heat prostate tissue to 'kill temperature' (55-57°C), while protecting surrounding anatomy, resulting in no procedural blood loss and quicker recovery times [2][4] - Real-time MRI thermography enables continuous visualization and autonomous temperature adjustments during the procedure, allowing for tailored therapy for each patient [2][4] Market Adoption and Growth - Following a transition to a Medicare model, the TULSA Procedure's adoption increased by 500%, indicating strong market demand and interest from urologists across Texas and surrounding states [2] - The innovative model developed by Texas Prostate bridges private-pay practices and Medicare-participating hospitals, facilitating broader access to advanced prostate care [2] Additional Products - Profound Medical also markets Sonalleve, an MRI-guided therapy for non-surgical treatment of various conditions, including pain palliation for bone metastases and gynecologic issues, which also emphasizes incision-free treatment and faster recovery [5][7] Regulatory Approvals - Profound Medical's technologies, including TULSA-PRO and Sonalleve, are approved in major global markets, including the United States, Europe, Canada, and several other countries, expanding access to innovative treatment options [6][7]

Core Viewpoint - Clearmind Medicine Inc. has filed a patent application in India for next-generation psychedelic-based compounds aimed at treating mental health disorders and addiction, enhancing its global intellectual property portfolio [1][2]. Group 1: Company Overview - Clearmind Medicine Inc. is a clinical-stage biotech company focused on developing non-hallucinogenic, second-generation neuroplastogen-derived therapeutics to address significant under-treated health issues, including alcohol use disorder [3]. - The company aims to research and commercialize psychedelic-based compounds as regulated medicines, foods, or supplements [3]. Group 2: Intellectual Property Development - The recent patent application is part of Clearmind's expanding global intellectual property portfolio, which currently includes nineteen patent families and 31 granted patents [2][4]. - The company has an exclusive worldwide licensing agreement with Yissum Research Development Company of the Hebrew University of Jerusalem, which supports its innovative compound development [2]. Group 3: Future Aspirations - Clearmind intends to seek additional patents for its compounds as opportunities arise and remains open to acquiring more intellectual property to strengthen its portfolio [4].

Core Viewpoint - Streamex Corp. refutes misinformation regarding the expiration of lock-up agreements and clarifies the actual number of shares involved in these agreements [1][2][6] Group 1: Lock-Up Agreements - The company confirms that the total number of shares subject to lock-up agreements is 42,887,599, not the previously reported 89,833,535 shares [2][3] - The lock-up agreements were entered into by certain directors and officers on January 22, 2026, in connection with financing on January 26, 2026 [3] - The individuals subject to these agreements do not hold options, warrants, or preferred stock that would be affected by the lock-up [3] Group 2: Financing Details - The financing conducted on January 26, 2026, was a confidentially marketed public offering, with all shares issued being freely tradable upon closing [4] - On March 26, 2026, co-founders Morgan Lekstrom and Henry McPhie voluntarily entered into new one-year lock-up agreements, committing not to sell or transfer shares without prior consent [5][6] Group 3: Company Position and Strategy - The co-founders express confidence in the company's position, citing significant capital on the balance sheet and the successful launch of the GLDY project with upcoming catalysts [6] - Streamex Corp. focuses on the tokenization and digitalization of commodity real-world assets, providing institutional-grade solutions that bridge traditional finance and blockchain markets [7]

Core Insights - Super League reported its strongest revenue quarter of the year in Q4 2025, with a focus on execution and a debt-free balance sheet [1][3] - The company has diversified its revenue streams and shifted towards scalable offerings, aiming for a profitable future [1][6] - The CEO highlighted a stronger foundation and clearer path to scale, targeting the gamer demographic as a valuable consumer segment [2] Financial Performance - For the full year 2025, Super League improved pro forma cash basis EBITDA by 31% year-over-year, with a notable 56% improvement in Q4 alone [4] - Gross margin expanded to 40% in 2025, up from 38% in 2024, indicating a more efficient operating model [4] - The company ended 2025 with over $14 million in cash and no debt, eliminating the need for future capital raises [5] Business Strategy - Super League has taken decisive actions to reshape its business, simplifying its capital structure and focusing on a more streamlined organization [5][6] - The company aims to position itself as an audience partner for brands rather than a channel-specific provider, enhancing its relevance in the digital advertising market [6][7] - Recent partnerships include collaborations with Regal Cinemas, H&R Block, and expanded relationships with major brands like Google and Disney [8] Future Outlook - Early 2026 activity is promising, with first-quarter revenue expected to exceed the prior year, driven by engagement from both returning and new clients [10] - The company anticipates reaching cash basis EBITDA profitability by year-end, supported by its recent acquisition of the Misfits Ads Division [9]

Group 1: Financial Results - The Supervisory Council of AS Tallinna Vesi has approved the audited annual report for 2025, which will be submitted to the Annual General Meeting of Shareholders for approval, with no changes from the previously published unaudited results [1] - The audited annual report for 2025 is available on Tallinna Vesi's website [1] Group 2: Dividend Policy - Tallinna Vesi has established a dividend policy aimed at distributing 50–80% of the company's annual profits to shareholders, providing clarity regarding future dividends [2] - The amount of dividends is determined annually based on the company's earnings, investment needs, liquidity position, and long-term financial objectives [2] Group 3: Dividend Proposal for 2025 - The Management Board proposes to distribute €0.57 per share as dividends, which represents 80% of the net profit for 2025 [4] - The total amount to be distributed as dividends is €11,400 thousand from the consolidated retained earnings of €85,783 thousand as of 31/12/2025, including a consolidated net profit of €14,242 thousand for 2025 [5] - The record date for shareholders entitled to dividends is set for 12/05/2026, with the ex-dividend date on 11/05/2026, and dividends will be paid on 20 May 2026 [3]

Core Viewpoint - Digitalist Group Plc has published its Financial Statements for 2025, along with the Board of Directors' report, Auditor's report, Corporate Governance Statement, and Remuneration Report, all available on the company's website [1][2]. Group 1: Financial Statements and Reports - The Financial Statements of 2025 include the Board of Directors' report and the Auditor's report, which are accessible at the company's investor relations page [1]. - The Corporate Governance Statement and the Remuneration Report are also published on the company's website, providing insights into governance practices and executive compensation [1]. - The Financial Statements have been prepared in accordance with the European Single Electronic Format (ESEF) reporting requirements, with primary statements labeled using XBRL tags [2]. Group 2: Audit and Compliance - KPMG Oy Ab has provided an independent auditor's reasonable assurance report on the ESEF financial statements, ensuring compliance with ISAE 3000 standards [2]. - The ESEF format report is available on the company's internet pages and as an attachment to the stock exchange release [2].

Core Viewpoint - Precision Optics Corporation has announced the pricing of its public offering of 2,777,777 shares at $3.60 per share, indicating strong interest from both existing and new institutional investors [1][2]. Group 1: Offering Details - The offering was oversubscribed and included participation from company executives, such as the President and CEO, who purchased shares at the public offering price [2]. - Lucid Capital Markets is the sole book-running manager for the offering, which is expected to close on or about March 30, 2026, subject to customary closing conditions [3]. - The company has granted the underwriter a 45-day option to purchase an additional 416,667 shares at the public offering price [3]. Group 2: Use of Proceeds - The net proceeds from the offering will be used for working capital and general corporate purposes [4]. Group 3: Company Overview - Precision Optics Corporation, founded in 1982, specializes in advanced optical instruments for the medical and defense/aerospace industries, leveraging proprietary technologies [7]. - The company provides services from product concept to mass manufacture, focusing on next-generation medical devices and defense applications [7].

Core Viewpoint - Heimstaden AB held its Annual General Meeting for 2026, making several key resolutions regarding financial statements, board members, and auditing [1][3]. Financial Resolutions - The financial statements for the year ending December 31, 2025, were adopted [3]. - The proposal for allocation of the Company's results was approved, with a decision to pay no dividends [3]. Board and Management - Discharge from liability was granted to the current Board Members and co-CEOs for their management in 2025 [3]. - Ivar Tollefsen, John Giverholt, Bente Landsnes, and Fredrik Reinfeldt were re-elected as Board Members [3]. Auditing - The registered auditing firm Ernst & Young Aktiebolag was re-elected as the external auditor, with Jonas Svensson appointed as the auditor in charge [3].

Core Insights - Alstom has secured a €915 million turnkey contract to deliver Belgrade's Metro Line 1, marking the first fully automated metro system in Serbia [1][11] - The project aims to alleviate surface congestion and enhance Belgrade's status as a leading European capital [2][3] Project Overview - The first phase of Metro Line 1 will cover 15 km with 15 stations, including 11 km of tunnels, significantly transforming the city's transit system [2] - The project will provide a reliable and safe alternative to road transit for nearly two million residents [3] Technological Aspects - Alstom will deliver a full turnkey metro solution, including 32 Metropolis driverless trains, signaling, telecommunications, and advanced cybersecurity systems [4][6] - The metro will utilize Alstom's Urbalis CBTC technology for fully automated operations, enabling high-capacity and reliable service [4][6] Economic and Strategic Implications - The project is supported by French government funding, highlighting strong bilateral cooperation between France and Serbia [5] - The introduction of driverless technology is expected to increase operational efficiency, passenger capacity, and safety [6] Company Background - Alstom is a leader in automated metro systems with nearly 30 driverless lines globally and over 50 years of experience in the industry [7] - The company generated revenues of €18.5 billion for the fiscal year ending March 2025, showcasing its strong market position [9]